News

Novo Nordisk’s weight-loss drug Wegovy has been surpassed in weekly U.S. prescriptions by Eli Lilly’s Zepbound, and now the ...
Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...
UnitedHealth Group (NYSE:UNH) has faced severe headwinds in 2025, with its stock plummeting over 50% from its April high.
Eli Lilly is making waves by acquiring SiteOne Therapeutics for up to $1 billion, eyeing a non-opioid chronic pain treatment.
Understand what the future of work looks like. Understand the factors impacting the future of work in medical devices. Learn what areas of healthcare ...